SCHEMBL31268871

SCHEMBL31268871

CC1(Oc2ncnc3c2nc(-c2ccc(CCCC(=O)O)cc2Cl)n3Cc2cccc(Cl)c2)CC1.COC(=O)CCOc1ccc(-c2nc3c(OC4(C)CC4)ncnc3n2Cc2cccc(Cl)c2)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TLR7 Q9NYK1 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ FFAR1 O14842 1/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ PLA2G2A P14555 4/20 0.32
▸ MAOB P27338 1/20 0.32
▸ PTGDR2 Q9Y5Y4 1/20 0.32
▸ SCN1A P35498 1/20 0.32
▸ SCN8A Q9UQD0 1/20 0.32
▸ CYSLTR2 Q9NS75 1/20 0.32
▸ CYSLTR1 Q9Y271 1/20 0.32
▸ S1PR1 P21453 1/20 0.32
▸ S1PR3 Q99500 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ PLA2G4A P47712 1/20 0.31
▸ P2RX3 P56373 1/20 0.31
▸ MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983523 0.91 PLA2G2A (0.38) TLR7FFAR4PLA2G2APTGDR2CNR1
SCHEMBL30983451 0.90 PLA2G2A (0.38) TLR7PLA2G2AMAOBPTGDR2SCN1A
SCHEMBL31269035 0.90 CNR1 (0.36) TLR7FFAR1FFAR4PLA2G2AMAOB
SCHEMBL31269373 0.90 PLA2G2A (0.37) TLR7PLA2G2AMAOBPTGDR2SCN1A
SCHEMBL31268872 0.90 PLA2G2A (0.37) TLR7PLA2G2AMAOBPTGDR2SCN1A
SCHEMBL31269020 0.90 FFAR4 (0.38) TLR7FFAR1FFAR4PTGDR2SCN1A
SCHEMBL31269376 0.87 PPARG (0.34) TLR7FFAR1PLA2G2AMAOBPTGDR2
SCHEMBL31268992 0.86 CNR1 (0.35) TLR7FFAR1FFAR4PLA2G2AMAOB
SCHEMBL31321937 0.85 PLA2G2A (0.40) PLA2G2A
SCHEMBL31269340 0.85 S1PR1 (0.36) KDM4EFFAR1FFAR4PLA2G2APTGDR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback